Meda Biotech llc.

Meda Biotech llc. www.nanomeda.com
Nano medicines using hybrid nanoengeenring

02/19/2020

Re: AACR Annual Meeting 2020 in San Diego, California

Abstract Control Number: 5723 *****Permanent Abstract Number: 1732****
Title: Hybrid-nanoengineering of an effective combination therapy for pancreatic cancer


Dear Dr. Briggs:

Your above-referenced abstract has been scheduled for presentation in a Poster Session at the AACR Annual Meeting 2020 in San Diego, California, and will be published in the 2020 Proceedings of the AACR. Presentation information pertaining to your abstract is below:

Session Category: Cancer Chemistry
Session Title: Targeted Delivery of Small Molecules and Biologics 1
Session Date and Time: Monday Apr 27, 2020 9:00 AM - 12:30 PM
Location: San Diego Convention Center, Exhibit Halls A-F, Poster Section 23
Poster Board Number: 18
Permanent Abstract Number: 1732 [Place this number on your poster board]

11/11/2018
08/02/2018

Join us to fight cancer

Address

Baton Rouge, LA

Website

Alerts

Be the first to know and let us send you an email when Meda Biotech llc. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram